Lite Strategy, Inc. (LITS)
1.11
+0.05
(+4.72%)
USD |
NASDAQ |
Sep 11, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
Lite Strategy Price to Book Value : 0.6866 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.6866 |
| September 10, 2026 | 0.6557 |
| September 09, 2026 | 0.6557 |
| September 08, 2026 | 0.6804 |
| September 04, 2026 | 0.7051 |
| September 03, 2026 | 0.6433 |
| September 02, 2026 | 0.6433 |
| September 01, 2026 | 0.6148 |
| August 31, 2026 | 0.6096 |
| August 28, 2026 | 0.6064 |
| August 27, 2026 | 0.6185 |
| August 26, 2026 | 0.6143 |
| August 25, 2026 | 0.6495 |
| August 24, 2026 | 0.6371 |
| August 21, 2026 | 0.6122 |
| August 20, 2026 | 0.5835 |
| August 19, 2026 | 0.5814 |
| August 18, 2026 | 0.5456 |
| August 17, 2026 | 0.5444 |
| August 14, 2026 | 0.5483 |
| August 13, 2026 | 0.5539 |
| August 12, 2026 | 0.57 |
| August 11, 2026 | 0.5574 |
| August 10, 2026 | 0.5382 |
| August 07, 2026 | 0.5613 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.5746 |
| August 05, 2026 | 0.591 |
| August 04, 2026 | 0.5841 |
| August 03, 2026 | 0.6069 |
| July 31, 2026 | 0.596 |
| July 30, 2026 | 0.6106 |
| July 29, 2026 | 0.5884 |
| July 28, 2026 | 0.60 |
| July 27, 2026 | 0.604 |
| July 24, 2026 | 0.6114 |
| July 23, 2026 | 0.6135 |
| July 22, 2026 | 0.6371 |
| July 21, 2026 | 0.6185 |
| July 20, 2026 | 0.6371 |
| July 17, 2026 | 0.6103 |
| July 16, 2026 | 0.6001 |
| July 15, 2026 | 0.6118 |
| July 14, 2026 | 0.6166 |
| July 13, 2026 | 0.585 |
| July 10, 2026 | 0.6247 |
| July 09, 2026 | 0.6142 |
| July 08, 2026 | 0.6043 |
| July 07, 2026 | 0.6007 |
| July 06, 2026 | 0.6035 |
| July 02, 2026 | 0.5879 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group, Inc. | 16.93 |
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| Anika Therapeutics, Inc. | 2.034 |
| Savara, Inc. | 7.578 |
Price to Book Value Related Metrics
| Price | 1.11 |
| Earnings Yield | -181.5% |
| Market Cap | 39.02M |